Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nicotrol launched in Austria as OTC

Oct. 24, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Therapeutic Antibodies and Altana enter alliance for emergency medicine products

Oct. 17, 1997

Orphan Medical licenses out European rights to Antizol

Sep. 23, 1997

Sano's combination patch shows promise for smoking cessation

Sep. 12, 1997

Guilford receives government contract for cocaine addiction research

Aug. 11, 1997

Algos and NIDA enter into collaboration for heroin addiction treatment

Aug. 7, 1997

Nicotine Inhaler launched in The Netherlands

July 24, 1997

Novartis prepares orally active iron chelators

July 23, 1997

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 5, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Associate degree: PTC’s hints of phase II HD efficacy studied
BioWorld
PTC Therapeutics Inc. CEO Matthew Klein said the firm “achieved all we set out to [achieve] in phase II” with PTC-518 in Huntington’s disease (HD), but it wasn’t...